Product Information
MEROPENEM IV 1 GM VIAL is a generic product labeled by Xellia Pharmaceuticals USA LLC, priced at $5.1627 per EA under NDC 70594007602. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
1 g/1
Manufacturer
Xellia Pharmaceuticals USA LLCNDC
70594007602
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
6/17/2026
Active Ingredients
MEROPENEMApproval Type
Generic (ANDA)
FDA Application
ANDA206141On Market Since
6/28/2021
Pharmacological Classes
Price Statistics
The NADAC for MEROPENEM IV 1 GM VIAL has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.1627 per EA |
|---|---|
| All-time high | $7.6153 (Nov 13, 2024) |
| All-time low | $5.1627 (Jun 17, 2026) |
| 52-week high | $5.8381 |
| 52-week low | $5.1627 |
| Median price | $5.7092 |
| Average price | $5.9090 |
| Largest weekly change | +15.4% (Oct 23, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEROPENEM IV 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for MEROPENEM IV 1 GM VIAL, manufactured by Xellia Pharmaceuticals USA LLC, is $5.1627 per EA (NDC 70594007602), effective Jun 24, 2026.
How has the price of MEROPENEM IV 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for MEROPENEM IV 1 GM VIAL has declined 11.4%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MEROPENEM IV 1 GM VIAL?
Since Apr 17, 2024, the NADAC for MEROPENEM IV 1 GM VIAL has ranged from a low of $5.1627 (Jun 17, 2026) to a high of $7.6153 (Nov 13, 2024), with a median of $5.7092 per EA.
Are there cheaper alternatives to MEROPENEM IV 1 GM VIAL?
2 NADAC-published products share the same active ingredient, strength, and dosage form as MEROPENEM IV 1 GM VIAL, but none are currently priced below it.
Who manufactures MEROPENEM IV 1 GM VIAL?
MEROPENEM IV 1 GM VIAL (NDC 70594007602) is labeled by Xellia Pharmaceuticals USA LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification